BlackRock Institutional Trust’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$32.7M	Buy	1,026,199 +146,247	+17%	+$4.54M	﹤0.01%	1607
2016 Q3	$31.9M	Buy	879,952 +73,601	+9%	+$2.05M	0.01%	1575
2016 Q2	$18.3M	Buy	806,351 +82,063	+11%	+$1.77M	﹤0.01%	1902
2016 Q1	$13.6M	Buy	724,288 +40,431	+6%	+$662K	﹤0.01%	2066
2015 Q4	$11.2M	Buy	683,857 +27,558	+4%	+$437K	﹤0.01%	2248
2015 Q3	$7.21M	Sell	656,299 -68,448	-9%	-$872K	﹤0.01%	2501
2015 Q2	$9.44M	Sell	724,747 -12,320	-2%	-$191K	﹤0.01%	2445
2015 Q1	$12.8M	Buy	737,067 +9,541	+1%	+$175K	﹤0.01%	2230
2014 Q4	$10.9M	Buy	727,526 +17,770	+3%	+$310K	﹤0.01%	2313
2014 Q3	$16.4M	Buy	709,756 +54,472	+8%	+$1.58M	﹤0.01%	2005
2014 Q2	$20.9M	Buy	+655,284	New	+$19.7M	﹤0.01%	1931